嘉事堂(002462) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 was ¥4,677,941,616.65, representing a decrease of 37.15% compared to ¥7,442,979,521.58 in the same period last year[5] - Net profit attributable to shareholders was ¥46,148,136.04, down 38.90% from ¥75,533,309.91 year-on-year[5] - Basic and diluted earnings per share decreased by 38.46% to ¥0.16 from ¥0.26 in the same period last year[5] - The company reported a significant drop in sales revenue from goods and services, which was ¥5,182,797,662.41, down 38.17% from ¥8,382,405,389.24[10] - Total operating revenue for the current period is ¥4,677,941,616.65, a decrease of 37.8% compared to ¥7,442,979,521.58 in the previous period[18] - Net profit for the current period is ¥75,129,771.10, a decline of 36.0% from ¥117,353,880.03 in the previous period[20] - The company recorded a total profit of ¥108,018,431.52 for the current period, down 33.1% from ¥161,576,235.41 in the previous period[19] Cash Flow - The net cash flow from operating activities was negative at -¥43,628,489.73, a decline of 115.85% compared to a positive cash flow of ¥275,331,117.53 in the previous year[5] - Cash flow from operating activities shows a net outflow of ¥43,628,489.73, a significant decrease from a net inflow of ¥275,331,117.53 in the previous period[23] - Investment activities generated a net cash flow of -¥805,348.22, a decline of 109.13% compared to ¥8,818,002.82 in the previous year[11] - The company’s investment activities resulted in a net cash outflow of ¥805,348.22, compared to a net inflow of ¥8,818,002.82 in the previous period[23] - The net increase in cash and cash equivalents was -¥69,216,102.01, a decrease of 220.27% from an increase of ¥57,550,565.79 in the previous year[11] Assets and Liabilities - Total assets at the end of the reporting period were ¥13,517,910,702.30, down 3.70% from ¥14,037,951,940.30 at the end of the previous year[5] - The total current assets amount to ¥12,505,806,134.77, a decrease from ¥13,004,908,179.96 at the beginning of the period, representing a decline of approximately 3.8%[15] - The total liabilities decreased from ¥7,973,111,304.62 to ¥7,378,004,245.45, a reduction of about 7.5%[17] - The cash and cash equivalents at the end of the period are ¥2,124,865,439.22, down from ¥2,223,287,855.91, a decrease of about 4.4%[15] - The accounts receivable decreased from ¥6,878,398,107.65 to ¥6,662,641,442.69, a decline of approximately 3.1%[15] - The inventory increased slightly from ¥2,739,440,537.06 to ¥2,752,875,854.37, an increase of about 0.5%[16] Shareholder Information - The total number of common shareholders at the end of the reporting period is 23,619[12] - The top 10 shareholders hold a combined 39.84% of the shares, with China Everbright Medical Health Industry Co., Ltd. holding 14.36% and China Everbright Group Co., Ltd. holding 14.12%[12] Equity and Retained Earnings - The retained earnings at the end of the period are ¥2,561,568,145.45, up from ¥2,515,420,009.41, an increase of approximately 1.8%[17] - The total equity increased from ¥6,064,840,635.68 to ¥6,139,906,456.85, reflecting an increase of about 1.2%[17] Operating Costs and Expenses - Total operating costs for the current period are ¥4,533,042,059.88, down 37.8% from ¥7,289,981,773.84 in the previous period[19] - The company incurred a tax expense of ¥32,888,660.42, compared to ¥44,222,355.38 in the previous period, reflecting a decrease of 25.6%[19] - The company reported a decrease in sales expenses to ¥74,957,767.59 from ¥149,240,297.12, a reduction of 49.7%[19]